4//SEC Filing
ABERNATHY JAMES PAUL 4
Accession 0001437749-26-001443
CIK 0001047335other
Filed
Jan 15, 7:00 PM ET
Accepted
Jan 16, 4:01 PM ET
Size
11.9 KB
Accession
0001437749-26-001443
Insider Transaction Report
Form 4
ABERNATHY JAMES PAUL
Director
Transactions
- Exercise/Conversion
Shares of Common Stock
[F1]2026-01-15$69.82/sh+7,500$523,650→ 43,894 total - Tax Payment
Shares of Common Stock
[F2][F3]2026-01-15$139.01/sh−3,732$518,785→ 40,162 total - Exercise/Conversion
Option to Purchase Common Stock [2022 Grant]
[F1]2026-01-15−7,500→ 0 totalExercise: $69.19From: 2023-05-05Exp: 2027-05-04→ Common Stock (7,500 underlying)
Holdings
- 7,500
Option to Purchase Common Stock [2023 Grant]
Exercise: $55.75From: 2024-05-04Exp: 2028-05-03→ Common Stock (7,500 underlying) - 7,500
Option to Purchase Common Stock [2024 Grant]
Exercise: $96.03From: 2025-05-09Exp: 2029-05-08→ Common Stock (7,500 underlying) - 7,500
Option to Purchase Common Stock [2025 Grant]
Exercise: $94.66From: 2026-05-08Exp: 2030-05-07→ Common Stock (7,500 underlying)
Footnotes (3)
- [F1]These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
- [F2]Shares were withheld by the Company to pay the exercise price.
- [F3]Total amount of shares beneficially owned following transactions reported on this form.
Signature
/s/ James Paul Abernathy|2026-01-16
Documents
Issuer
NATIONAL HEALTHCARE CORP
CIK 0001047335
Entity typeother
Related Parties
1- filerCIK 0001261687
Filing Metadata
- Form type
- 4
- Filed
- Jan 15, 7:00 PM ET
- Accepted
- Jan 16, 4:01 PM ET
- Size
- 11.9 KB